Literature DB >> 12842452

Distinct gene expression of osteopontin in patients with ulcerative colitis.

Hideki Masuda1, Yasuo Takahashi, Satoshi Asai, Tadatoshi Takayama.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is a multifactorial disorder of unknown etiology. Few studies have applied genome-wide gene expression analysis in colon tissue samples of UC. We report the analysis of mucosal gene expression in UC and noninflamed control specimens.
MATERIALS AND METHODS: This study included 7 UC patients who received a total colectomy because of severe total colitis. Normal control colon tissues were obtained at least 10 cm from the area of pathology in 3 colon cancer patients. Ten colonic tissue samples (7 UC and 3 normal control samples) were subjected to high-density oligonucleotide array analysis. To compare differences in the level of gene expression between UC and control samples, Mann-Whitney U-test was used, with significance set at P < 0.05.
RESULTS: Twenty-five genes had a 3.0 approximately 23.4-fold higher mRNA expression in UC samples compared with normal samples, whereas three genes had a 3.0 approximately 3.4-fold lower expression in UC samples compared with normal samples. Two genes showing more than a 10-fold increase expression in UC samples were a macrophage metalloelastase (L23808) and a osteopontin (AF052124). It has been said that macrophage metalloelastase is related to ulcer formation of the intestine, whereas osteopontin plays an important role in the pathogenesis of systemic lupus erythematosus and rheumatoid arthritis.
CONCLUSION: Our present study supports the previous report that macrophage metalloelastase is related to ulcer formation of UC, and it also indicates the possibility that osteopontin plays an important role in the pathogenesis of UC via increased immune activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842452     DOI: 10.1016/s0022-4804(03)00046-5

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  13 in total

1.  Osteopontin biomarker in inflammatory bowel disease, animal models and target for drug discovery.

Authors:  Manuela G Neuman
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

2.  Osteopontin: a new addition to the constellation of cytokines which drive T helper cell type 1 responses in Crohn's disease.

Authors:  J N Gordon; T T MacDonald
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

Review 3.  The future of molecular approaches to inflammatory bowel disease.

Authors:  Boyko Kabakchiev; Smita Halder; Mark S Silverberg
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

4.  The cytokine osteopontin modulates the severity of rotavirus diarrhea.

Authors:  Ellen E Rollo; Scott J Hempson; Ajay Bansal; Ernest Tsao; Iman Habib; Susan R Rittling; David T Denhardt; Erich R Mackow; Robert D Shaw
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Osteopontin mediates Citrobacter rodentium-induced colonic epithelial cell hyperplasia and attaching-effacing lesions.

Authors:  Eytan Wine; Grace Shen-Tu; Mélanie G Gareau; Harvey A Goldberg; Christoph Licht; Bo-Yee Ngan; Esben S Sorensen; James Greenaway; Jaro Sodek; Ron Zohar; Philip M Sherman
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

6.  Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL/6 mice.

Authors:  Angelika Goncalves DaSilva; Lucy Liaw; V Wee Yong
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

7.  Plasma osteopontin predicts inflammatory bowel disease activities.

Authors:  Shihoko Komine-Aizawa; Hideki Masuda; Takerou Mazaki; Motomi Shiono; Satoshi Hayakawa; Tadatoshi Takayama
Journal:  Int Surg       Date:  2015-01

8.  Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma.

Authors:  Yuji Toiyama; Akira Mizoguchi; Kazushi Kimura; Toshimitsu Araki; Shigeyuki Yoshiyama; Kouhei Sakaguchi; Chikao Miki; Masato Kusunoki
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

9.  Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.

Authors:  Mika Suzuki; Evangeline Mose; Christine Galloy; David Tarin
Journal:  Am J Pathol       Date:  2007-07-09       Impact factor: 4.307

10.  Osteopontin expression by CD103- dendritic cells drives intestinal inflammation.

Authors:  Evangelia Kourepini; Maria Aggelakopoulou; Themis Alissafi; Nikolaos Paschalidis; Davina C M Simoes; Vily Panoutsakopoulou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.